Français

Mental Wellness Program

Bio-Citalopram citalopram

Evaluated tools to help you understand your treatment, track what changes and know who to talk to.

Selective serotonin reuptake inhibitor (SSRI) · ATC N06AB04

These tools apply to every medication containing citalopram, whatever the manufacturer.

Where are you in your treatment?

Essentials to get started

Tools by topic

Understand your treatment

How citalopram works, and what to expect.

Take care of yourself day to day

Therapy, stress management and support, at your own pace.

  • Website

    Relief — self-management workshops

    10- to 12-week group workshops, online or in person in several Quebec regions, to live better with anxiety, depression or bipolar disorder.

    ReliefFree

  • Website

    Bounce Back

    Guided self-help program: phone coaching, practical workbooks and short videos to manage low mood, stress and anxiety.

    Canadian Mental Health Association (CMHA) – Quebec DivisionFree

  • Video

    Building connections and being well surrounded

    Why social connections protect mental health, with practical ideas to build and keep them.

    Mouvement Santé mentale QuébecFree

  • App

    Prezens

    Short breathing, meditation and mindfulness exercises to pause and find calm.

    Emergence asblFree

  • App

    MindDay

    Daily online coaching based on recognized strategies and mindfulness, to better understand thoughts and emotions.

    mindDay SASPaid or limited trial

  • Website

    Équilia — CBT and mindfulness program

    Free, self-paced 6-lesson online program combining cognitive behavioural therapy and mindfulness. No waiting list.

    Équilia research team (CIHR project, Quebec–Ontario collaboration)Free

Track what changes

Note how you feel to see how things evolve, and bring it to your appointments.

  • App

    Daylio

    Mood journal: log how you feel and what you did, then spot patterns. Handy to bring to your appointments.

    Relaxio s.r.o.Limited free version

  • Website

    MesOutils.ca

    Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.

    Association québécoise de prévention du suicide (AQPS) / CETI-SMDIFree

Know when to call

What is expected, what should make you call, and who to contact.

  • Article

    Understanding antidepressant medications, part 1: how to use them safely

    What antidepressants do, how long they take to work, and which side effects are common at the start.

    Canadian Medication Appropriateness and Deprescribing Network (CADeN)Free

  • Article

    Drugs for treatment of depression

    Consumer reference on antidepressant classes, how they act, and their side effects.

    Merck Manual (Consumer Version)Free

  • Website

    MesOutils.ca

    Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.

    Association québécoise de prévention du suicide (AQPS) / CETI-SMDIFree

Bio-Citalopram products

DIN Strength Form DPD status Program
02448475 10 mg TABLET Dormant (not currently sold) Yes
02448491 20 mg TABLET Dormant (not currently sold) Yes
02448513 40 mg TABLET Dormant (not currently sold) Yes

Other citalopram DINs on the market 70

70 products from other manufacturers. If your DIN is in this list, the tools on this page apply to you too.

DIN BrandManufacturer Strength Form DPD status
02374617 AG-CITALOPRAMANGITA PHARMA INC. 10 mg TABLET Marketed
02513676 AG-CITALOPRAM TABLETSANGITA PHARMA INC. 10 mg TABLET Marketed
02339390 AG-CITALOPRAMANGITA PHARMA INC. 20 mg TABLET Marketed
02513684 AG-CITALOPRAM TABLETSANGITA PHARMA INC. 20 mg TABLET Marketed
02543060 AG-CITALOPRAM TABLETSANGITA PHARMA INC. 30 mg TABLET Marketed
02339404 AG-CITALOPRAMANGITA PHARMA INC. 40 mg TABLET Marketed
02513692 AG-CITALOPRAM TABLETSANGITA PHARMA INC. 40 mg TABLET Marketed
02246056 APO-CITALOPRAMAPOTEX INC 20 mg TABLET Marketed
02246057 APO-CITALOPRAMAPOTEX INC 40 mg TABLET Marketed
02275562 AURO-CITALOPRAMAURO PHARMA INC 20 mg TABLET Marketed
02275570 AURO-CITALOPRAMAURO PHARMA INC 40 mg TABLET Marketed
02370085 JAMP-CITALOPRAMJAMP PHARMA CORPORATION 10 mg TABLET Marketed
02430517 CITALOPRAMJAMP PHARMA CORPORATION 10 mg TABLET Marketed
02313405 JAMP-CITALOPRAMJAMP PHARMA CORPORATION 20 mg TABLET Marketed
02430541 CITALOPRAMJAMP PHARMA CORPORATION 20 mg TABLET Marketed
02542439 JAMP CITALOPRAM TABLETSJAMP PHARMA CORPORATION 30 mg TABLET Approved, not yet marketed
02313413 JAMP-CITALOPRAMJAMP PHARMA CORPORATION 40 mg TABLET Marketed
02430568 CITALOPRAMJAMP PHARMA CORPORATION 40 mg TABLET Marketed
02429535 CITALOPRAMJUBILANT GENERICS LIMITED 10 mg TABLET Approved, not yet marketed
02429543 CITALOPRAMJUBILANT GENERICS LIMITED 20 mg TABLET Approved, not yet marketed
02429551 CITALOPRAMJUBILANT GENERICS LIMITED 40 mg TABLET Approved, not yet marketed
02295431 ACT CITALOPRAMKNIGHT THERAPEUTICS INC. 30 mg TABLET Approved, not yet marketed
02296152 CTP 30KNIGHT THERAPEUTICS INC. 30 mg TABLET Marketed
02303256 RIVA-CITALOPRAMLABORATOIRE RIVA INC. 10 mg TABLET Marketed
02303264 RIVA-CITALOPRAMLABORATOIRE RIVA INC. 20 mg TABLET Marketed
02303272 RIVA-CITALOPRAMLABORATOIRE RIVA INC. 40 mg TABLET Marketed
02239606 CELEXA 10 MGLUNDBECK CANADA INC 10 mg TABLET Approved, not yet marketed
02239607 CELEXA 20 MGLUNDBECK CANADA INC 20 mg TABLET Marketed
02239608 CELEXA 40 MGLUNDBECK CANADA INC 40 mg TABLET Marketed
02532123 M-CITALOPRAMMANTRA PHARMA INC 10 mg TABLET Marketed
02467836 M-CITALOPRAMMANTRA PHARMA INC 20 mg TABLET Marketed
02467844 M-CITALOPRAMMANTRA PHARMA INC 40 mg TABLET Marketed
02369664 IPG-CITALOPRAMMARCAN PHARMACEUTICALS INC 10 mg TABLET Approved, not yet marketed
02371871 MAR-CITALOPRAMMARCAN PHARMACEUTICALS INC 10 mg TABLET Marketed
02302535 IPG-CITALOPRAMMARCAN PHARMACEUTICALS INC 20 mg TABLET Approved, not yet marketed
02371898 MAR-CITALOPRAMMARCAN PHARMACEUTICALS INC 20 mg TABLET Marketed
02302543 IPG-CITALOPRAMMARCAN PHARMACEUTICALS INC 40 mg TABLET Approved, not yet marketed
02371901 MAR-CITALOPRAMMARCAN PHARMACEUTICALS INC 40 mg TABLET Marketed
02429691 MINT-CITALOPRAMMINT PHARMACEUTICALS INC 10 mg TABLET Marketed
02566125 MINT-CITALOPRAM SOLUTIONMINT PHARMACEUTICALS INC 10 mg SOLUTION Approved, not yet marketed
02429705 MINT-CITALOPRAMMINT PHARMACEUTICALS INC 20 mg TABLET Marketed
02429713 MINT-CITALOPRAMMINT PHARMACEUTICALS INC 40 mg TABLET Marketed
02409003 NATCO-CITALOPRAMNATCO PHARMA (CANADA) INC 10 mg TABLET Marketed
02443880 NATCO-CITALOPRAMNATCO PHARMA (CANADA) INC 20 mg TABLET Marketed
02443899 NATCO-CITALOPRAMNATCO PHARMA (CANADA) INC 40 mg TABLET Marketed
02555999 NB-CITALOPRAMNB PHARMA INC. 10 mg TABLET Marketed
02556006 NB-CITALOPRAMNB PHARMA INC. 20 mg TABLET Marketed
02556014 NB-CITALOPRAMNB PHARMA INC. 40 mg TABLET Approved, not yet marketed
02477637 NRA-CITALOPRAMNORA PHARMA INC 10 mg TABLET Marketed
02477645 NRA-CITALOPRAMNORA PHARMA INC 20 mg TABLET Marketed
02477653 NRA-CITALOPRAMNORA PHARMA INC 40 mg TABLET Marketed
02427389 PENDO-CITALOPRAMPENDOPHARM DIVISION OF PHARMASCIENCE INC 20 mg TABLET Approved, not yet marketed
02270609 PMS-CITALOPRAMPHARMASCIENCE INC 10 mg TABLET Marketed
02248010 PMS-CITALOPRAMPHARMASCIENCE INC 20 mg TABLET Marketed
02248011 PMS-CITALOPRAMPHARMASCIENCE INC 40 mg TABLET Marketed
02325047 PRO-CITALOPRAMPRO DOC LIMITEE 10 mg TABLET Marketed
02257513 PRO-CITALOPRAMPRO DOC LIMITEE 20 mg TABLET Marketed
02257521 PRO-CITALOPRAMPRO DOC LIMITEE 40 mg TABLET Marketed
02445719 CITALOPRAMSANIS HEALTH INC 10 mg TABLET Marketed
02353660 CITALOPRAMSANIS HEALTH INC 20 mg TABLET Marketed
02353679 CITALOPRAMSANIS HEALTH INC 40 mg TABLET Marketed
02431629 SEPTA-CITALOPRAMSEPTA PHARMACEUTICALS INC 10 mg TABLET Dormant (not currently sold)
02355272 SEPTA-CITALOPRAMSEPTA PHARMACEUTICALS INC 20 mg TABLET Dormant (not currently sold)
02355280 SEPTA-CITALOPRAMSEPTA PHARMACEUTICALS INC 40 mg TABLET Dormant (not currently sold)
02387948 CITALOPRAMSIVEM PHARMACEUTICALS ULC 10 mg TABLET Marketed
02387956 CITALOPRAMSIVEM PHARMACEUTICALS ULC 20 mg TABLET Marketed
02387964 CITALOPRAMSIVEM PHARMACEUTICALS ULC 40 mg TABLET Marketed
02312336 TEVA-CITALOPRAMTEVA CANADA LIMITED 10 mg TABLET Marketed
02293218 TEVA-CITALOPRAMTEVA CANADA LIMITED 20 mg TABLET Marketed
02293226 TEVA-CITALOPRAMTEVA CANADA LIMITED 40 mg TABLET Marketed

For pharmacists and healthcare professionals

Every tool was evaluated against public criteria. You can share this page directly with your patients: no DIN is required.